Vmn1r132 Activators
Vmn1r132 activators form a diverse group of chemical compounds that interact with and modulate the vomeronasal 1 receptor subtype 132, a receptor that plays a role in the chemical sensing system of certain organisms. These activators are characterized by their ability to bind to or influence the receptor, leading to its stimulation and subsequent cellular responses. The primary mechanism through which these activators work involves the modulation of intracellular cyclic adenosine monophosphate (cAMP) levels, a critical second messenger in various biochemical pathways. Different activators operate through distinct pathways to influence cAMP concentrations and receptor activity. Some directly stimulate enzymes like adenylyl cyclase to boost cAMP production, while others inhibit phosphodiesterase enzymes, preventing cAMP breakdown and thereby causing its accumulation within the cell.
The chemical structures of Vmn1r132 activators are varied, encompassing small molecules, peptides, and other biologically active compounds. Forskolin, for example, is a diterpene found in the roots of the Coleus forskohlii plant that directly stimulates adenylyl cyclase, leading to an increase in intracellular cAMP levels. Other activators, such as IBMX and rolipram, are synthetic molecules that inhibit specific phosphodiesterase isoforms, thus preventing the degradation of cAMP. This class of activators also includes molecules like sildenafil, known for its action on phosphodiesterase 5, which primarily increases cyclic guanosine monophosphate (cGMP) levels but can also have a secondary effect on cAMP signaling. Additionally, the group includes compounds like cholera toxin, which modifies the G-protein coupled receptor signaling by permanently activating Gs alpha subunit, leading to prolonged adenylyl cyclase activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, leading to an increase in cAMP levels. This accumulation of cAMP can enhance the signaling pathways that vomeronasal 1 receptor 132 is part of, leading to its functional activation. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), which leads to an increase in intracellular cAMP levels, thereby enhancing the cAMP signaling cascades that vomeronasal 1 receptor 132 utilizes, ultimately leading to its activation. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Cilostamide is a selective inhibitor of phosphodiesterase 3 (PDE3), which prevents the breakdown of cAMP, leading to accumulation of cAMP and thus enhancing the signaling pathways involving cAMP that vomeronasal 1 receptor 132 is part of. | ||||||
CGS 21680 Hydrochloride | 124431-80-7 | sc-211062 sc-211062A | 10 mg 50 mg | $292.00 $1044.00 | 7 | |
CGS 21680 is an adenosine A2A receptor agonist that can lead to activation of adenylyl cyclase and subsequent increase in cAMP levels, enhancing the signaling pathways that involve vomeronasal 1 receptor 132, leading to its activation. | ||||||
ESI-09 | 263707-16-0 | sc-507491 | 5 mg | $230.00 | ||
ESI-09 is an Epac-specific inhibitor that can indirectly act as an activator by preventing the degradation of cAMP, which is necessary for Epac activation. Elevated cAMP levels can enhance the signaling pathways that involve vomeronasal 1 receptor 132, leading to its activation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a non-selective beta-adrenergic receptor agonist that can increase cAMP levels by stimulating adenylyl cyclase, enhancing the signaling pathways that vomeronasal 1 receptor 132 is involved in, leading to its activation. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cAMP analog that can activate cAMP-dependent protein kinases and other proteins regulated by cAMP, enhancing the signaling pathways that involve vomeronasal 1 receptor 132, leading to its activation. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast is a selective inhibitor of phosphodiesterases, particularly PDE5, which can lead to increased cGMP levels and indirectly enhance the cAMP signaling pathways that vomeronasal 1 receptor 132 utilizes, thus potentially enhancing its functional activity. | ||||||